UPLC-Q-TOF/MS-based metabonomic studies on the intervention effects of aspirin eugenol ester in atherosclerosis hamsters.

Abstract

Based on the pro-drug principle, aspirin and eugenol were used to synthesize aspirin eugenol ester (AEE) by esterification reaction. In present study, the anti-atherosclerosis effects of AEE were investigated in hamsters with the utilization of metabonomic approach based on UPLC-Q-TOF/MS. Biochemical parameters and histopathological injures in stomach, liver and aorta were evaluated. In atherosclerotic hamster, oral administration of AEE normalized biochemical profile such as reducing TG, TCH and LDL, and significantly reduced body weight gain, alleviated hepatic steatosis and improved pathological lesions in aorta. Slight damages in stomach mucous were found in AEE group. Plasma and urine samples in control, model and AEE groups were scattered in the partial least squares-discriminate analysis (PLS-DA) score plots. Thirteen endogenous metabolites in plasma such as lysophosphatidylcholine (LysoPC), leucine and valine, and seventeen endogenous metabolites in urine such as citric acid, phenol sulphate and phenylacetylglycine were selected as potential biomarkers associated with atherosclerosis. They were considered to be in response to anti-atherosclerosis effects of AEE, mainly involved in glycerophospholipid metabolism, amino acid metabolism and energy metabolism. This study extended the understanding of endogenous alterations of atherosclerosis and offered insights into the pharmacodynamic activity of AEE.

• Authors: Ning Ma, Yajun Yang, Xiwang Liu, Xiaojun Kong, Shihong Li, Zhe Qin, Zenghua Jiao, Jianyong Li
• Journal: Scientific reports (Sci Rep) Vol. 7 Issue 1 Pg. 10544 (09 05 2017) ISSN: 2045-2322 [Electronic] England
• PMID: 28874840 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Anti-Inflammatory Agents
• Biomarkers
• Lysophosphatidylcholines
• Phenols
• aspirin eugenol ester
• Citric Acid
• Eugenol
• phenylacetylglycine
• Leucine
• Valine
• Aspirin
• Glycine

Topics

• Animals
• Anti-Inflammatory Agents (pharmacology, therapeutic use)
• Aspirin (analogs & derivatives, pharmacology, therapeutic use)
• Atherosclerosis (blood, drug therapy, urine)
• Biomarkers (blood, urine)
• Citric Acid (urine)
• Cricetinae
• Eugenol (analogs & derivatives, pharmacology, therapeutic use)
• Glycine (analogs & derivatives, urine)
• Leucine (blood)
• Lysophosphatidylcholines (blood)
• Male
• Mesocricetus
• Metabolome (drug effects)
• Phenols (urine)
• Valine (blood)